University Hospital Limerick is a hospital located in Dooradoyle, Limerick, Ireland. It is managed by UL Hospitals Group.

There are 562 beds in MidWestern Regional Hospital.

During the past decade, MidWestern Regional Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MidWestern Regional Hospital" #1 sponsor was "Cancer Trials Ireland" with 4 trials, followed by "Celgene" with 3 trials sponsored, "Mid Western Regional Hospital, Ireland" with 2 trials sponsored, "BioMarin Pharmaceutical" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MidWestern Regional Hospital" #1 collaborator was "BeiGene" with 1 trials as a collaborator, "Cancer International Research Group (CIRG)" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "MidWestern Regional Hospital" are "Breast Cancer" (2 trials), "Metastatic Breast Cancer" (2 trials), "Abdominal Aortic Aneurysm" (1 trials), "B-cell Chronic Lymphocytic Leukemia" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "MidWestern Regional Hospital" in a lesser frequency.

Most popular intervention types in "MidWestern Regional Hospital" are "Drug" (8 trials), "Other" (3 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Trastuzumab" (2 trials), "5-Fluorouracil" (1 trials), "Bevacizumab" (1 trials) and "CC-5013 plus dexamethasone" (1 trials). Other intervention names were less common.

The vast majority of trials in "MidWestern Regional Hospital" are 11 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "MidWestern Regional Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in MidWestern Regional Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in MidWestern Regional Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".